Diabetes Devices Market Size Is Expected To Reach USD 41.88 Billion In 2028 - Reports and Data

The global diabetes devices market size is expected to reach USD 41.88 billion in 2028 and register a CAGR of 6.4% over the forecast period, according to the latest report by Reports and Data. Major factors boosting market revenue growth are rising prevalence of diabetes, increasing investment in the development of more advanced diabetic care devices, and increasing demand for insulin delivery devices. Diabetes devices are used to measure and effectively manage blood sugar level of patients suffering from diabetes. Regular monitoring of blood sugar levels is a crucial part of diabetes treatment and management.

Diabetes devices are widely used in diagnostic centers, hospitals, and homecare. Hospitals segment accounted for major revenue share in the global market in 2020. Growing number of multispecialty private hospitals in developing countries and increasing demand for hospital-based treatment options are major factors driving revenue growth of this segment.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @https://www.reportsanddata.com/sample-enquiry-form/1488

Now that the tide is turning, more worldwide growth in the pharmaceutical business is likely to come from emerging nations, particularly China, where health systems are rapidly developing. Despite the fact that only a few acquisitions were announced or completed, tremendous growth is projected in the future years.

Significantly, China's adoption of health insurance and broader healthcare reforms last year effectively created a market of one billion people overnight. However, generic medications account for 76% of the Chinese market, making it difficult for European and American multinationals to capitalize on market prospects.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @https://www.reportsanddata.com/report-detail/diabetes-device-market

In the past, developed countries were hesitant to trade in emerging markets, with only a few multinational pharmaceutical companies making acquisitions in Latin America, India, or China. However, with tremendous development potential in the East, major businesses in the pharmaceutical industry should explore acquisitions in China aggressively to gain a presence.

Request a customization of the report @https://www.reportsanddata.com/request-customization-form/1488

Some Key Highlights From the Report:

In August 2021, Smart Meter launched iGlucose Blood Glucose Monitoring (BGM) System. This new BGM system is capable of conducting tests in a simple and reliable way. With the help of this new system, caregivers can monitor and manage blood glucose levels of patients suffering from gestational diabetes.
Insulin delivery devices segment accounted for largest revenue share in the global market in 2020. This can be attributed to rising technological advancements in insulin delivery systems and increasing prevalence of type-1 diabetes globally.

Major players in the market include Braun, DexCom, Inc., Abbott, F. Hoffman-La Roche Ltd., Ascensia Diabetes Care Holdings AS, LifeScan, AgaMatrix Holdings LLC, Acon Laboratories, Inc., ARKRAY USA, Inc., and Becton, Dickinson and Company.

For the purpose of this report, Reports and Data has segmented diabetes devices market based on type, distribution channels, end-use, and region:

Type Outlook (Revenue, USD Billion; 2018-2028)

Blood Glucose Monitoring Systems
Self-Monitoring Devices
Continuous Glucose Monitoring Devices
Lancets
Test Strips or Test Papers
Insulin Delivery Devices
Insulin Pumps
Insulin Pens
Insulin Syringes and Needles
Diabetes Management Mobile Applications

Distribution Channels Outlook (Revenue, USD Billion; 2018-2028)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Diabetes Clinics
Others

End-use Outlook (Revenue, USD Billion; 2018-2028)

Diagnostic Centers
Hospitals
Homecare

Regional Outlook (Revenue, USD Billion; 2018-2028)

North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Sweden
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
U.A.E.
South Africa
Israel
Rest of MEA

Press Release Available @ https://www.reportsanddata.com/press-release/global-diabetes-devices-market

Growing advancements in medical therapies to drive market growth

The pharmaceutical and healthcare industry is driven by rapid advancements in customized therapies, medical devices, and surgical procedures. Integration of advanced technologies to accelerate research and development and manufacturing and production activities are some other factors driving market growth.

High prices of certain drugs might affect revenue growth

Launch of high-priced drugs to treat rare and chronic diseases and lesser affordability in middle- and low-income regions might limit their adoption and restrain market growth going ahead. In addition, less knowledge and awareness regarding advanced treatment approaches and lower adoption of advanced technologies might further hamper market growth over the forecast period.

Explore More Industry Research by Reports and Data:

Laser Fiber In Medical Applications Market @ https://www.biospace.com/article/the-increasing-use-of-laser-fiber-in-diagnostic-procedures-is-expected-to-drive-the-laser-fiber-in-medical-applications-market-growth/

Multiparameter Patient Monitoring Market @ https://www.biospace.com/article/portable-monitors-are-expected-to-hold-a-dominant-position-in-the-multiparameter-patient-monitoring-market/

Genomics Market @ https://www.biospace.com/article/increasing-the-number-of-government-sponsored-genome-projects-will-expect-to-boost-genomics-market-revenue-growth-by-2030/

Antibody Production Market @ https://www.biospace.com/article/increased-demand-for-therapeutic-antibodies-is-expected-to-drive-antibody-production-market-growth/

Contact Us:

Nikhil Morankar
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.